🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oppenheimer ups Addus HomeCare shares target on IL rate hike

EditorEmilio Ghigini
Published 07/06/2024, 13:06
ADUS
-

On Friday, Oppenheimer adjusted its financial outlook for Addus HomeCare (NASDAQ:ADUS) shares, a provider of comprehensive home care services. The firm raised its price target on the company's shares to $130.00, up from the previous $118.00, while reiterating an Outperform rating.

The revision follows Addus HomeCare's management remarks at a recent competitor conference, where they discussed expected rate increases in Illinois. The company anticipates an approximately 5.5% increase in Illinois rates starting January 1, 2025.

This rate hike is projected to boost revenues by $23 million and contribute around $0.25 per share to annualized earnings. Some of this anticipated growth is already accounted for in Oppenheimer's existing financial model.

In response to these projections and the shift to 2025 estimates, Oppenheimer has increased its earnings per share (EPS) forecasts for Addus HomeCare for fiscal years 2025 and 2026. The new estimates stand at $5.56 and $6.09, respectively, up from the prior predictions of $5.45 and $5.97.

The firm's analyst highlighted Addus HomeCare's potential for benefiting from significant opportunities, including possible mergers and acquisitions.

Additionally, the extension of the "80/20" rule was mentioned as a favorable development for the company. This rule is likely a regulatory or industry-specific guideline that impacts Addus HomeCare's operations, although further details were not disclosed in the context provided.

In other recent news, Addus HomeCare has been the subject of several financial analysts' reports. Stephens raised its price target for Addus HomeCare to $128, citing the strength of the Illinois market, which contributes significantly to the company's revenues.

RBC Capital Markets also increased its price target for Addus HomeCare to $129 following the company's first-quarter earnings, which surpassed expectations.

The firm highlighted the company's strategic divestiture of its New York operations as a positive move aligning with its growth strategy.

Furthermore, despite the divestiture of its New York State Personal Care Services assets, Addus HomeCare maintained its Buy rating and a price target of $119, reflecting confidence in the company's financial prospects.

The divestiture, which could reach $23 million, is expected to have a moderate impact on the company's earnings before interest, taxes, depreciation, and amortization.

Finally, TD Cowen adjusted their price target on shares of Addus HomeCare to $119 from $105, following the company's first-quarter earnings report that showed the company's EBITDA surpassing estimates.

The firm cited improved general and administrative leverage and higher Personal Care Services rates as contributing factors to the company's strong financial results. These developments underline recent strategic and financial movements within Addus HomeCare.

InvestingPro Insights

Recent data from InvestingPro underscores the positive sentiment from Oppenheimer regarding Addus HomeCare (NASDAQ:ADUS). The company's market capitalization stands at a robust $1.88 billion, reflecting investor confidence. Moreover, Addus HomeCare is trading at a Price-to-Earnings (P/E) ratio of 28.34, which adjusts to a slightly lower 26.7 when considering the last twelve months as of Q1 2024, suggesting a reasonable valuation relative to near-term earnings growth. Additionally, the company's revenue growth for the same period is a solid 11.45%, indicating a strong upward trajectory in financial performance.

InvestingPro Tips highlight that analysts have revised their earnings upwards for the upcoming period, which aligns with Oppenheimer's raised EPS forecasts. Furthermore, the Relative Strength Index (RSI) suggests the stock is in overbought territory, a signal that investor interest in Addus HomeCare is quite high. With the stock trading near its 52-week high and a 29.9% price uptick over the last six months, the market sentiment appears to be very optimistic.

For those seeking to delve deeper into Addus HomeCare's financials and stock performance, the full suite of InvestingPro Tips available at Investing.com/pro/ADUS includes a total of 13 additional insights. Investors can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enhancing their investment decision-making with comprehensive analysis and real-time data.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.